aro mutations in Salmonella enterica cause defects in cell wall and outer membrane integrity
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
18310348
PubMed Central
PMC2347392
DOI
10.1128/jb.00053-08
PII: JB.00053-08
Knihovny.cz E-zdroje
- MeSH
- albuminy farmakologie MeSH
- alkyltransferasy a aryltransferasy genetika MeSH
- aminokyseliny aromatické biosyntéza genetika MeSH
- antibakteriální látky farmakologie MeSH
- bakteriální geny * MeSH
- bakteriální léková rezistence genetika MeSH
- buněčná membrána účinky léků genetika MeSH
- buněčná stěna účinky léků genetika MeSH
- EDTA farmakologie MeSH
- fosfoenolpyruvát metabolismus MeSH
- klonování DNA MeSH
- komplement farmakologie MeSH
- mutace MeSH
- ovotransferin farmakologie MeSH
- plazmidy genetika MeSH
- Salmonella enteritidis účinky léků enzymologie genetika MeSH
- Salmonella typhimurium účinky léků enzymologie genetika MeSH
- sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů MeSH
- sérum MeSH
- testy genetické komplementace MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- albuminy MeSH
- alkyltransferasy a aryltransferasy MeSH
- aminokyseliny aromatické MeSH
- antibakteriální látky MeSH
- EDTA MeSH
- fosfoenolpyruvát MeSH
- komplement MeSH
- ovotransferin MeSH
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase MeSH Prohlížeč
In this study we characterized aro mutants of Salmonella enterica serovars Enteritidis and Typhimurium, which are frequently used as live oral vaccines. We found that the aroA, aroD, and aroC mutants were sensitive to blood serum, albumen, EDTA, and ovotransferrin, and this defect could be complemented by an appropriate aro gene cloned in a plasmid. Subsequent microarray analysis of gene expression in the aroD mutant in serovar Typhimurium indicated that the reason for this sensitivity might be the upregulation of murA. To confirm this, we artificially overexpressed murA from a multicopy plasmid, and this overexpression caused sensitivity of the strain to albumen and EDTA but not to serum and ovotransferrin. We concluded that attenuation of aro mutants is caused not only by their inability to synthesize aromatic metabolites but also by their defect in cell wall and outer membrane functions associated with decreased resistance to components of innate immune response.
Zobrazit více v PubMed
Bar-Tana, J., B. J. Howlett, and R. Hertz. 1980. Ubiquinone synthetic pathway in flagellation of PubMed PMC
Bennett, G. M., A. Seaver, and P. H. Calcott. 1981. Effect of defined lipopolysaccharide core defects on resistance of PubMed PMC
Brown, E. D., E. I. Vivas, C. T. Walsh, and R. Kolter. 1995. MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in PubMed PMC
Conlan, J. W., and R. J. North. 1992. Early pathogenesis of infection in the liver with the facultative intracellular bacteria PubMed PMC
Cooper, G. L., L. M. Venables, M. J. Woodward, and C. E. Hormaeche. 1994. Vaccination of chickens with strain CVL30, a genetically defined PubMed PMC
Datsenko, K. A., and B. L. Wanner. 2000. One-step inactivation of chromosomal genes in PubMed PMC
Duncan, K., S. Chaudhuri, M. S. Campbell, and J. R. Coggins. 1986. The overexpression and complete amino acid sequence of PubMed PMC
Duncan, K., and J. R. Coggins. 1986. The PubMed PMC
Eschenburg, S., W. Kabsch, M. L. Healy, and E. Schonbrunn. 2003. A new view of the mechanisms of UDP- PubMed
Everest, P., J. Ketley, S. Hardy, G. Douce, S. Khan, J. Shea, D. Holden, D. Maskell, and G. Dougan. 1999. Evaluation of PubMed PMC
Galloway, S. M., and C. R. Raetz. 1990. A mutant of PubMed
Govoni, G., and P. Gros. 1998. Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm. Res. 47277-284. PubMed
Halsey, T. A., A. Vazquez-Torres, D. J. Gravdahl, F. C. Fang, and S. J. Libby. 2004. The ferritin-like Dps protein is required for PubMed PMC
Hoiseth, S. K., and B. A. D. Stocker. 1981. Aromatic-dependent PubMed
Hoiseth, S. K., and B. A. Stocker. 1985. Genes PubMed PMC
Horii, T., T. Kimura, K. Sato, K. Shibayama, and M. Ohta. 1999. Emergence of fosfomycin-resistant isolates of Shiga-like toxin-producing PubMed PMC
Hormaeche, C. E., H. S. Joysey, L. Desilva, M. Izhar, and B. A. Stocker. 1991. Immunity conferred by Aro PubMed
Lowe, D. C., T. C. Savidge, D. Pickard, L. Eckmann, M. F. Kagnoff, G. Dougan, and S. N. Chatfield. 1999. Characterization of candidate live oral PubMed PMC
Methner, U., P. A. Barrow, D. Gregorova, and I. Rychlik. 2004. Intestinal colonization-inhibition and virulence of PubMed
Nnalue, N. A. 1990. Mice vaccinated with a non-virulent, aromatic-dependent mutant of PubMed
Perez-Gutierrez, C., C. M. Llompart, M. Skurnik, and J. A. Bengoechea. 2007. Expression of the PubMed PMC
Robertsson, J. A., A. A. Lindberg, S. Hoiseth, and B. A. Stocker. 1983. PubMed PMC
Rychlik, I., L. Cardova, M. Sevcik, and P. A. Barrow. 2000. Flow cytometry characterisation of PubMed
Rychlik, I., G. Martin, U. Methner, M. Lovell, L. Cardova, A. Sebkova, M. Sevcik, J. Damborsky, and P. A. Barrow. 2002. Identification of PubMed
Shaio, M. F., and H. Rowland. 1985. Bactericidal and opsonizing effects of normal serum on mutant strains of PubMed PMC
Silva, E. N., G. H. Snoeyenbos, O. M. Weinack, and C. F. Smyser. 1981. Studies on the use of 9R strain of PubMed
Splichal, I., I. Trebichavsky, A. Splichalova, and P. A. Barrow. 2005. Protection of gnotobiotic pigs against PubMed
Stevenson, G., B. Neal, D. Liu, M. Hobbs, N. H. Packer, M. Batley, J. W. Redmond, L. Lindquist, and P. Reeves. 1994. Structure of the O antigen of PubMed PMC
Stinavage, P., L. E. Martin, and J. K. Spitznagel. 1989. O antigen and lipid A phosphoryl groups in resistance of PubMed PMC
Stritzker, J., J. Janda, C. Schoen, M. Taupp, S. Pilgrim, I. Gentschev, P. Schreier, G. Geginat, and W. Goebel. 2004. Growth, virulence, and immunogenicity of PubMed PMC
Tacket, C. O., M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro, R. Edelman, D. Pickard, G. Dougan, S. N. Chatfield, and M. M. Levine. 1997. Safety of live oral PubMed PMC
Tacket, C. O., M. B. Sztein, S. S. Wasserman, G. Losonsky, K. L. Kotloff, T. L. Wyant, J. P. Nataro, R. Edelman, J. Perry, P. Bedford, D. Brown, S. Chatfield, G. Dougan, and M. M. Levine. 2000. Phase 2 clinical trial of attenuated PubMed PMC
Trebichavsky, I., A. Splichalova, I. Rychlik, H. Hojna, Y. Muneta, Y. Mori, and I. Splichal. 2006. Attenuated PubMed
Tusher, V. G., R. Tibshirani, and G. Chu. 2001. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 985116-5121. PubMed PMC